Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Coagulation Factor XIV/Protein C Antibody, R&D Systems™

Sheep Polyclonal Antibody
Supplier: R&D Systems AF4885SP
This item is not returnable.
View return policy
Description
Coagulation Factor XIV/Protein C Polyclonal specifically detects Coagulation Factor XIV/Protein C in Mouse samples. It is validated for Western Blot, Immunoprecipitation.Specifications
Coagulation Factor XIV/Protein C | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
Anticoagulant protein C, APC, Autoprothrombin IIA, Blood coagulation factor XIV, EC 3.4.21, EC 3.4.21.69, PC, PROC, PROC1, Protein C, protein C (inactivator of coagulation factors Va and VIIIa), vitamin K-dependent protein C | |
Sheep | |
Affinity Purified | |
RUO | |
5624 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Immunoprecipitation | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
P33587 | |
PROC | |
Chinese hamster ovary cell line CHO-derived recombinant mouse Coagulation Factor XIV/Protein C Ile19-Leu460 Accession # P33587 | |
25 μg | |
Primary | |
Detects mouse Coagulation Factor XIV/Protein C in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 10% cross-reactivity with recombinant human Protein C is observed. | |
Mouse | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction